ORAGENICS INC
Pagina dedicata companiei ORAGENICS INC listata cu simbolurile US.OGEN, US.OGENc
Descriere companieModificare
Oragenics, Inc. (https://www.oragenics.com/) is a developing-stage company. The Company is focused on developing infectious diseases including coronaviruses and multidrug-resistant organisms. The Company’s pre-clinical product candidates includes OG716 and Terra CoV-2. It, through its subsidiary, is engaged in the research and development of Terra CoV-2 vaccine product candidate. It is also engaged in the development of its lead lantibiotic candidate, OG716, to treat Clostridium difficile.
Grafic actiuni companieModificare